{"id":"W2037473701","doi":"10.1016/j.eururo.2010.11.024","title":"Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"ca_institutions":"Huntington Society of Canada","funders":"National Institute on Minority Health and Health Disparities","keywords":"Medicine; Lower urinary tract symptoms; Urology; Hyperplasia; Urinary system; Prostate; Gynecology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002011048,0.001302341,0.001941505,0.0004591118,0.0003564978,0.000595048,0.0006132018,0.001601653,0.003387205],"category_scores_gemma":[0.001471747,0.0002932238,0.001492044,0.0003710706,0.0006916905,0.0005906108,0.000191188,0.00225833,0.0007879888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004009236,"about_ca_system_score_gemma":0.0009503288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00080711,"about_ca_topic_score_gemma":0.002046288,"domain_scores_codex":[0.9994557,0.0002720447,0.0000279751,0.00006421483,0.0000990637,0.0000809288],"domain_scores_gemma":[0.9989058,0.0004217611,0.0002898418,0.00009871954,0.00007688469,0.0002069873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2997416,0.05658925,0.005698724,0.00306089,0.002051882,0.000629504,0.0004035625,0.002738374,0.1332541,0.000865351,0.008996855,0.4859699],"study_design_scores_gemma":[0.2293257,0.6870896,0.02801712,0.000145935,0.0009463013,0.001633323,0.00007352844,0.002003484,0.03924598,0.0005313352,0.01089892,0.00008869469],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9642896,0.01369498,0.007390996,0.001237661,0.0004269497,0.004651008,0.002119747,0.0006050966,0.005583983],"genre_scores_gemma":[0.9710686,0.007795565,0.007282082,0.002001645,0.0004753092,0.002395158,0.00361196,0.0001376173,0.005231976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003387205,"threshold_uncertainty_score":0.01133138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02433445432554206,"score_gpt":0.3299207012625544,"score_spread":0.3055862469370123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}